Obagi® Medical Products Wins Best Skincare in the Second Annual NewBeauty Magazine Choice Awards

-- Obagi® Nu-Derm System named The Best Skin Care System at a Doctor's Office -- LONG BEACH, Calif.--(BUSINESS WIRE)--Jan. 4, 2012-- Obagi®Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, has been recognized, for the second consecutive year, for having "The Best Skin-Care System at a Doctor's Office" by NewBeauty Magazine. The prestigious Beauty Choice Award was given for the Obagi Nu Derm System and will be featured in the Winter 2012 issue of NewBeauty Magazine.

"We are honored to be named, once again, the top skincare system from a physician's office," said Jim Hartman, Vice President of Global Marketing and Business Development at Obagi Medical Products. "Being acknowledged in 2011 and now in 2012, by consumers, along with such an esteemed group of beauty insiders and industry professionals, makes it that much more significant."

The awards recognize the best products on the market as determined by thousands of NewBeauty readers, as well as the magazine's editors and renowned beauty experts.

"There is no doubt that consumers' beauty products are highly coveted items that we just can't live without," NewBeauty Editor-in-Chief, Yolanda Toh Bucher says, "And when we find something that really works? We can't help but share our secret with our friends, family and just about anyone who will listen, that's what our Beauty Choice Awards celebrate."

The Obagi Nu-Derm System is the #1, prescription-strength, physician-dispensed skincare system on the market and is designed to address aging skin. After using Nu-Derm, skin is improved for a healthier, more resilient appearance.

About Obagi Medical Products, Inc.

Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, and is a leading provider of, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeutics™ technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles. Obagi Medical's portfolio, which includes cosmetic, over-the-counter and prescription products, including 4% hydroquinone, is sold and promoted only through physician offices and requires education by a physician on proper use. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly stable vitamin C serums), Obagi Condition &Enhance® for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm® Eye Treatment and Obagi CLENZIderm® M.D. acne therapeutic systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to dry skin, and Obagi ELASTIderm Décolletage System, Obagi Rosaclear® System, Obagi ELASTILash® Eyelash Solution, Obagi Blue Peel RADIANCETM, and Nu-Derm® Sun Shield for information.

Blue Peel RADIANCE, ELASTILash and Penetrating Therapeutics are trademarks, and Obagi, the Obagi logo, Condition & Enhance, ELASTIderm, Nu-Derm, Obagi-C, Obagi CLENZIderm and Rosaclear are registered trademarks, of Obagi Medical Products, Inc. and/or its affiliates in the United States and certain other countries.

Source: Obagi® Medical Products, Inc.

Creative Media Marketing
Sara Skirboll, [phone]
[e-mail]